News & Updates
Filter by Specialty:
Should experts rename ‘fatty liver disease’ to reduce stigma?
Individuals with nonalcoholic fatty liver disease (NAFLD) may face stigma from the disease or comorbidities, but the perceptions of shame differ across patients, healthcare providers, geographic locations, and subspecialties, reveals a study.
Should experts rename ‘fatty liver disease’ to reduce stigma?
11 Mar 2024
Novel investigational combo a breakthrough in HIV treatment?
Phase II data presented at CROI 2024 demonstrated the ability of an investigational, long-acting, oral once-weekly regimen comprising islatravir, a nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a first-in-class capsid inhibitor, to maintain viral suppression at week 24 in virologically suppressed people living with HIV (PWH).
Novel investigational combo a breakthrough in HIV treatment?
11 Mar 2024
Twin study: Adverse childhood experiences linked to poor adult mental health outcomes
Adverse childhood experiences (ACEs) are associated with depression, anxiety, substance use disorder, and stress-related disorders in adulthood, a twin cohort study has shown.
Twin study: Adverse childhood experiences linked to poor adult mental health outcomes
11 Mar 2024
Cefepime–taniborbactam bests meropenem for complicated UTI
Patients with complicated urinary tract infection (UTI) may fare better with cefepime–taniborbactam than with meropenem, with the combination having been associated with much higher treatment success rates in the phase III CERTAIN-1 trial.